Assembly Biosciences (ASMB) Interest Expenses (2010 - 2011)
Assembly Biosciences (ASMB) recorded quarterly Interest Expenses of -$302327.0 in Q4 2011, down 206.49% quarter-over-quarter from $283907.0 in Q3 2011, and up 86.63% on a YoY basis from -$161989.4 in Q4 2010.
Assembly Biosciences (ASMB) Interest Expenses (2010 - 2011) Analysis & Trends
Assembly Biosciences' Interest Expenses history runs 2 years deep, the most recent figure standing at -$302327.0 for Q4 2011.
- In Q4 2011, Interest Expenses rose 86.63% year-over-year to -$302327.0; the TTM figure through Sep 2012 stood at -$302327.0 (up 83.81% YoY), while the FY2011 annual figure was $116664.0, down 94.29% from the prior year.
- Interest Expenses was -$302327.0 for Q4 2011 at Assembly Biosciences, down from $283907.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.3 million in Q3 2010 to a low of -$2.3 million in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -302,327.00 |
| Dec 31, 2011 | -302,327.00 |
| Sep 30, 2011 | 283,907.00 |
| Sep 30, 2011 | 283,907.00 |
| Jun 30, 2011 | 65,907.00 |
| Jun 30, 2011 | 65,907.00 |
| Mar 31, 2011 | 44,663.00 |
| Mar 31, 2011 | 44,663.00 |
| Dec 31, 2010 | -2.26 Mn |
| Dec 31, 2010 | -2.26 Mn |
| Sep 30, 2010 | 1.27 Mn |
| Sep 30, 2010 | 1.27 Mn |
| Jun 30, 2010 | 684,457.00 |
| Jun 30, 2010 | 684,457.00 |